172 related articles for article (PubMed ID: 8528057)
1. Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomas.
Fenchel K; Bergmann L; Wijermans P; Engert A; Pralle H; Mitrou PS; Diehl V; Hoelzer D
Leuk Lymphoma; 1995 Aug; 18(5-6):485-92. PubMed ID: 8528057
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia.
Bergmann L; Fenchel K; Jahn B; Mitrou PS; Hoelzer D
Ann Oncol; 1993 May; 4(5):371-5. PubMed ID: 8353071
[TBL] [Abstract][Full Text] [Related]
3. Present status of purine analogs in the therapy of chronic lymphocytic leukemias.
Bergmann L
Leukemia; 1997 Apr; 11 Suppl 2():S29-34. PubMed ID: 9178835
[TBL] [Abstract][Full Text] [Related]
4. [Treatment with fludarabine of lymphoid neoplasms with low grade malignity resistant to treatment or in relapse].
Briones J; Montserrat E; Urbano-Ispizua A; Esteve J; Colomer D; López-Guillermo A; Bosch F; Hadjieu E; Rozman C
Med Clin (Barc); 1996 Jun; 107(3):86-9. PubMed ID: 8754493
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.
Stelitano C; Morabito F; Kropp MG; Callea V; Iuliano F; Oriana V; Levato D; Nobile F; Molica S; Brugiatelli M
Haematologica; 1999 Apr; 84(4):317-23. PubMed ID: 10190945
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.
Keating MJ; O'Brien S; Lerner S; Koller C; Beran M; Robertson LE; Freireich EJ; Estey E; Kantarjian H
Blood; 1998 Aug; 92(4):1165-71. PubMed ID: 9694704
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German Low-Grade Non-Hodgkin's Lymphoma Study Group.
Hiddemann W; Unterhalt M; Pott C; Wörmann B; Sandford D; Freund M; Engert A; Gassmann W; Holtkamp W; Seufert J
Semin Oncol; 1993 Oct; 20(5 Suppl 7):28-31. PubMed ID: 8235693
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine.
Montillo M; Cafro AM; Tedeschi A; Brando B; Oreste P; Veronese S; Rossi V; Cairoli R; Pungolino E; Morra E
Haematologica; 2002 Jul; 87(7):695-700; discussion 700. PubMed ID: 12091119
[TBL] [Abstract][Full Text] [Related]
9. The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders.
Lazzarino M; Orlandi E; Baldanti F; Furione M; Pagnucco G; Astori C; Arcaini L; Viglio A; Paulli M; Gerna G; Bernasconi C
Br J Haematol; 1999 Dec; 107(4):877-82. PubMed ID: 10606897
[TBL] [Abstract][Full Text] [Related]
10. Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia.
Savage DG; Cohen NS; Hesdorffer CS; Heitjan D; Oster MW; Garrett TJ; Bar M; del Prete S; March R; Lonberg M; Talbot S; Mears JG; Flamm M; Taub RN; Nichols G
Leuk Lymphoma; 2003 Mar; 44(3):477-81. PubMed ID: 12688318
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine and prednisone in pretreated and refractory B-chronic lymphocytic leukemia (B-CLL) in advanced stages.
De Rossi G; Mauro FR; Caruso R; Monarca B; Mandelli F
Haematologica; 1993; 78(3):167-71. PubMed ID: 8375746
[TBL] [Abstract][Full Text] [Related]
12. Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma.
Hendry L; Bowen A; Matutes E; Swansbury J; Catovsky D
Leuk Lymphoma; 2004 May; 45(5):945-50. PubMed ID: 15291353
[TBL] [Abstract][Full Text] [Related]
13. Activity of fludarabine in refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma--the Jerusalem experience.
Gillis S; Dann EJ; Cass Y; Rochlemer RR; Polliack A
Leuk Lymphoma; 1994 Sep; 15(1-2):173-5. PubMed ID: 7858497
[TBL] [Abstract][Full Text] [Related]
14. Fludarabine monophosphate as salvage for refractory chronic lymphocytic leukaemia.
Pillay GS; Wood L; Jacobs P
S Afr Med J; 1996 Aug; 86(8):949-51. PubMed ID: 8823419
[TBL] [Abstract][Full Text] [Related]
15. Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.
Schulz H; Klein SK; Rehwald U; Reiser M; Hinke A; Knauf WU; Aulitzky WE; Hensel M; Herold M; Huhn D; Hallek M; Diehl V; Engert A;
Blood; 2002 Nov; 100(9):3115-20. PubMed ID: 12384407
[TBL] [Abstract][Full Text] [Related]
16. Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
Zinzani PL; Levrero MG; Lauria F; Rondelli D; Zaja F; Russo D; Fanin R; De Rossi G; Mauro FR; Bendandi M; Gozzetti A; Dianzani F; Mandelli F; Tura S
Haematologica; 1994; 79(1):55-60. PubMed ID: 15378949
[TBL] [Abstract][Full Text] [Related]
17. Fludarabine in lymphoproliferative disorders: the Royal Marsden Hospital experience.
O'Brien ME; Matutes E; Cunningham D; Hill M; Emmett E; Ellis PA; Milan S; Hickish T; Mercieca J; Catovsky D
Leuk Lymphoma; 1994; 14 Suppl 2():17-23. PubMed ID: 7881347
[TBL] [Abstract][Full Text] [Related]
18. Fludarabine phosphate for the treatment of low grade lymphoid malignancy.
Whelan JS; Davis CL; Rule S; Ranson M; Smith OP; Mehta AB; Catovsky D; Rohatiner AZ; Lister TA
Br J Cancer; 1991 Jul; 64(1):120-3. PubMed ID: 1713049
[TBL] [Abstract][Full Text] [Related]
19. Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
Zinzani PL; Bendandi M; Magagnoli M; Rondelli D; de Vivo A; Benni M; Zamagni E; Cavo M; Tura S
Eur J Haematol; 1997 Aug; 59(2):82-8. PubMed ID: 9293855
[TBL] [Abstract][Full Text] [Related]
20. Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy.
Marotta G; Bigazzi C; Lenoci M; Tozzi M; Bocchia M; Lauria F
Haematologica; 2000 Dec; 85(12):1268-70. PubMed ID: 11114133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
